Lifetime risk and years lived free of total cardiovascular disease

John T Wilkins1, Hongyan Ning, Jarett Berry

  • 1Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. j-wilkins@fsm.northwestern.edu

JAMA
|November 3, 2012
PubMed

Insights

Lifetime risk for cardiovascular disease (CVD) is high for everyone, even those with optimal risk factors. Maintaining healthy habits significantly increases years lived free of CVD.

Area of Science:

  • Cardiovascular epidemiology
  • Preventive cardiology
  • Public health

Background:

  • Lifetime risk estimates for total cardiovascular disease (CVD) are crucial for projecting future disease burden and aiding clinical communication.
  • Previous studies have not reported comprehensive lifetime risk estimates for total CVD.

Purpose of the Study:

  • To calculate lifetime risk estimates for total CVD based on age and risk factor profiles.
  • To estimate the number of years individuals live free from CVD across different risk factor strata.

Main Methods:

  • Pooled survival analysis utilizing over 900,000 person-years of data from five major US cohort studies.
  • Analysis included participants free of CVD at baseline, with data on blood pressure, cholesterol, diabetes, and smoking status.
  • Total CVD events, including fatal and nonfatal outcomes, were tracked.

Main Results:

  • Overall lifetime CVD risk at age 45 was 60.3% for men and 55.6% for women.
  • Individuals with elevated or major risk factors faced lifetime risks exceeding 50% by age 95.
  • Even those with optimal risk factors at age 55 had significant lifetime CVD risks, yet lived up to 14 years longer free of CVD compared to those with multiple risk factors.

Conclusions:

  • Lifetime risk for total CVD is substantial across all individuals, including those with optimal risk factors in middle age.
  • Maintaining optimal cardiovascular risk factor levels in middle age is strongly associated with a significantly longer duration of life free from CVD.
Abstract

Related Concept Videos

Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...